Public health emergencies often occur in the place least likely to be able to manage them, and western Africa was poorly prepared for the latest outbreak of Ebola. However, as much as an overwhelmed world might fervently hope that it will remain an African problem, its impact will be felt far beyond the borders of Liberia and its neighbours. Ebola outranks everything else on a crowded global agenda today, and the quicker we acknowledge this, the more effectively it can be contained.
It could be said that the investment of resources into a cure that could carry a price-tag of £1m plus per person to turn a profit is, in purely financial terms, a ridiculous thing to do. With many pharmaceutical companies linking their moral accountability solely with their shareholders, for those who contract unprofitable, neglected diseases it's often a case of "bad luck" and in many cases "goodbye".